Thailand FDA Approves YONDELIS® for Advanced Soft Tissue Sarcoma
The Thailand Food and Drug Administration has approved YONDELIS® (trabectedin) for the treatment of adult patients with advanced soft tissue sarcoma, following an exclusive licensing agreement between PharmaMar and Specialised Therapeutics.